Difference between revisions of "Pacritinib (Vonjo)"
Jump to navigation
Jump to search
(Created page with "A dual JAK-2 and FLT3 inhibitor in clinical trials. [http://www.celltherapeutics.com/pacritinib Link to company website] Category:Investigational [[Category:Kinase inhibi...") |
m |
||
| Line 1: | Line 1: | ||
A dual JAK-2 and FLT3 inhibitor in clinical trials. [http://www.celltherapeutics.com/pacritinib Link to company website] | A dual JAK-2 and FLT3 inhibitor in clinical trials. [http://www.celltherapeutics.com/pacritinib Link to company website] | ||
| + | [[Category:Drug index]] | ||
[[Category:Investigational]] | [[Category:Investigational]] | ||
| + | |||
[[Category:Kinase inhibitors]] | [[Category:Kinase inhibitors]] | ||
[[Category:FLT3 inhibitors]] | [[Category:FLT3 inhibitors]] | ||
[[Category:JAK inhibitors]] | [[Category:JAK inhibitors]] | ||
Revision as of 16:25, 24 October 2014
A dual JAK-2 and FLT3 inhibitor in clinical trials. Link to company website